Patents Assigned to The Children's Memorial Hospital
-
Publication number: 20130102541Abstract: The invention provides compositions comprising one or more isolated factors from a microenvironment of human embryonic stem cells (hESCs), including, but not limited to, Lefty and inhibitors of Nodal. The invention also provides methods of utilizing factors derived from human embryonic stem cells (hESC) and their microenvironment to treat and prevent tumor formation and progression and to inhibit tumor cell aggressiveness. The invention further provides methods of inhibiting tumor cell growth and/or treating aggressive tumors in a mammal comprising administering to the mammal, having at least one tumor cell present in its body, an effective amount of an inhibitor of Nodal activity.Type: ApplicationFiled: December 20, 2011Publication date: April 25, 2013Applicant: Children's Memorial HospitalInventors: Mary Jessica Hendrix, Lynne-Marie Postovit, Richard Edward Barnet Seftor, Elisabeth Ann Seftor
-
Publication number: 20120322857Abstract: The invention provides compositions comprising one or more isolated factors from a microenvironment of human embryonic stem cells (hESCs), including, but not limited to, Lefty and inhibitors of Nodal. The invention also provides methods of utilizing factors derived from human embryonic stem cells (hESC) and their microenvironment to treat and prevent tumor formation and progression and to inhibit tumor cell aggressiveness. The invention further provides methods of inhibiting tumor cell growth and/or treating aggressive tumors in a mammal comprising administering to the mammal, having at least one tumor cell present in its body, an effective amount of an inhibitor of Nodal activity.Type: ApplicationFiled: August 10, 2012Publication date: December 20, 2012Applicant: Children's Memorial HospitalInventors: Mary Jessica Hendrix, Lynne-Marie Postovit, Richard Edward Barnet Seftor, Elisabeth Ann Seftor
-
Patent number: 8106004Abstract: The invention provides compositions comprising one or more isolated factors from a microenvironment of human embryonic stem cells (hESCs), including, but not limited to, Lefty and inhibitors of Nodal. The invention also provides methods of utilizing factors derived from human embryonic stem cells (hESC) and their microenvironment to treat and prevent tumor formation and progression and to inhibit tumor cell aggressiveness. The invention further provides methods of inhibiting tumor cell growth and/or treating aggressive tumors in a mammal comprising administering to the mammal, having at least one tumor cell present in its body, an effective amount of an inhibitor of Nodal activity.Type: GrantFiled: March 10, 2008Date of Patent: January 31, 2012Assignee: Children's Memorial HospitalInventors: Mary Jessica Hendrix, Lynne-Marie Postovit, Richard Edward Barnet Seftor, Elisabeth Ann Seftor
-
Publication number: 20100273707Abstract: The invention provides compositions comprising one or more isolated factors from a microenvironment of human embryonic stem cells (hESCs), including, but not limited to, Lefty and inhibitors of Nodal. The invention also provides methods of utilizing factors derived from human embryonic stem cells (hESC) and their microenvironment to treat and prevent tumor formation and progression and to inhibit tumor cell aggressiveness. The invention further provides methods of inhibiting tumor cell growth and/or treating aggressive tumors in a mammal comprising administering to the mammal, having at least one tumor cell present in its body, an effective amount of an inhibitor of Nodal activity.Type: ApplicationFiled: January 6, 2010Publication date: October 28, 2010Applicant: CHILDREN'S MEMORIAL HOSPITALInventors: Mary Jessica Hendrix, Lynne-Maire Postovit, Richard Edward Barnet Seftor, Elisabeth Ann Seftor
-
Patent number: 7811814Abstract: A vector and a method are provided for delivering a nucleic acid to a nervous system cell. The vector includes a first nucleic acid, a second nucleic acid, inverted terminal repeats of adeno-associated virus, and a tetracycline-off regulatable promoter system that includes a first promoter operably linked to the first nucleic acid and a second promoter operably linked to the second nucleic acid. The promoters drive expression in opposite directions and away from the inverted terminal repeats. The method includes providing a recombinant adeno-associated viral (rAAV) vector and administering the vector to a nervous system cell. Expression of a product from the first nucleic acid is regulatable by the promoter system.Type: GrantFiled: September 16, 2008Date of Patent: October 12, 2010Assignee: Children's Memorial HospitalInventors: Martha C. Bohn, Lixin Jiang, Neva C. West, Elio F. Vanin
-
Publication number: 20100105610Abstract: The invention provides compositions comprising one or more isolated factors from a microenvironment of human embryonic stem cells (hESCs), including, but not limited to, Lefty and inhibitors of Nodal. The invention also provides methods of utilizing factors derived from human embryonic stem cells (hESC) and their microenvironment to treat and prevent tumor formation and progression and to inhibit tumor cell aggressiveness. The invention further provides methods of inhibiting tumor cell growth and/or treating aggressive tumors in a mammal comprising administering to the mammal, having at least one tumor cell present in its body, an effective amount of an inhibitor of Nodal activity.Type: ApplicationFiled: July 26, 2007Publication date: April 29, 2010Applicant: CHILDREN'S MEMORIAL HOSPITALInventors: Mary Jessica Hendrix, Lynne-Maire Postovit, Richard Edward Barnet Seftor, Elisabeth Ann Seftor
-
Patent number: 7666423Abstract: The invention provides compositions comprising one or more isolated factors from a microenvironment of human embryonic stem cells (hESCs), including, but not limited to, Lefty and inhibitors of Nodal. The invention also provides methods of utilizing factors derived from human embryonic stem cells (hESC) and their microenvironment to treat and prevent tumor formation and progression and to inhibit tumor cell aggressiveness. The invention further provides methods of inhibiting tumor cell growth and/or treating aggressive tumors in a mammal comprising administering to the mammal, having at least one tumor cell present in its body, an effective amount of an inhibitor of Nodal activity.Type: GrantFiled: July 26, 2007Date of Patent: February 23, 2010Assignee: Children's Memorial HospitalInventors: Mary Jessica Hendrix, Lynne-Marie Postovit, Richard Edward Barnet Seftor, Elisabeth Ann Seftor
-
Publication number: 20090186801Abstract: The invention provides compositions comprising one or more isolated factors from a microenvironment of human embryonic stem cells (hESCs), including, but not limited to, Lefty and inhibitors of Nodal. The invention also provides methods of utilizing factors derived from human embryonic stem cells (hESC) and their microenvironment to treat and prevent tumor formation and progression and to inhibit tumor cell aggressiveness. The invention further provides methods of inhibiting tumor cell growth and/or treating aggressive tumors in a mammal comprising administering to the mammal, having at least one tumor cell present in its body, an effective amount of an inhibitor of Nodal activity.Type: ApplicationFiled: March 10, 2008Publication date: July 23, 2009Applicant: CHILDREN'S MEMORIAL HOSPITALInventors: Mary Jessica Hendrix, Lynne Marie Postovit, Richard Edward Barnet Seftor, Elisabeth Ann Seftor
-
Patent number: 7456015Abstract: A vector and a method are provided for delivering a nucleic acid to a nervous system cell. The vector includes a first nucleic acid, a second nucleic acid, inverted terminal repeats of adeno-associated virus, and a tetracycline-off regulatable promoter system that includes a first promoter operably linked to the first nucleic acid and a second promoter operably linked to the second nucleic acid. The promoters drive expression in opposite directions and away from the inverted terminal repeats. The method includes providing a recombinant adeno-associated viral (rAAV) vector and administering the vector to a nervous system cell. Expression of a product from the first nucleic acid is regulatable by the promoter system.Type: GrantFiled: November 15, 2006Date of Patent: November 25, 2008Assignee: Children's Memorial HospitalInventors: Martha C. Bohn, Lixin Jiang, Neva C. West, Elio F. Vanin
-
Publication number: 20080050362Abstract: The invention provides compositions comprising one or more isolated factors from a microenvironment of human embryonic stem cells (hESCs), including, but not limited to, Lefty and inhibitors of Nodal. The invention also provides methods of utilizing factors derived from human embryonic stem cells (hESC) and their microenvironment to treat and prevent tumor formation and progression and to inhibit tumor cell aggressiveness. The invention further provides methods of inhibiting tumor cell growth and/or treating aggressive tumors in a mammal comprising administering to the mammal, having at least one tumor cell present in its body, an effective amount of an inhibitor of Nodal activity.Type: ApplicationFiled: July 26, 2007Publication date: February 28, 2008Applicant: CHILDREN'S MEMORIAL HOSPITALInventors: Mary Hendrix, Lynne-Marie Postovit, Richard Seftor, Elisabeth Seftor
-
Patent number: 4112926Abstract: A method of measuring hyperactivity includes determining the total number of movements of the subject as well as the number of movements which occur at a rate exceeding a preselected threshold. When the rate exceeds the threshold, biofeedback conditioning may be employed to alert the patient in order to condition him against such activity. An apparatus employing the method includes a counting unit worn on the belt of the subject. The counting unit records movement detected by a set of mercury switches. The total number of times a mercury switch is opened is counted as well as the number of times the rate threshold is exceeded. This information is stored in the counters for subsequent evaluation. An oscillator circuit gated by the counting unit provides an audible signal to the subject when the rate threshold is exceeded. A readout and display circuit is utilized for obtaining the information stored in the counting unit.Type: GrantFiled: December 8, 1976Date of Patent: September 12, 1978Assignee: The Children's Memorial HospitalInventors: Jerome L. Schulman, Jay Kaplan